<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mismatch repair-deficient <z:hpo ids='HP_0003002'>breast cancers</z:hpo> may be identified in <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> mutation carriers, and have clinicopathological features in common with mismatch repair-deficient colorectal and <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancers</z:e> such as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-infiltrating lymphocytes and poor differentiation </plain></SENT>
<SENT sid="1" pm="."><plain>Mismatch repair-deficient <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> frequently show mucinous differentiation associated with upregulation of chromosome 11 mucins </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to compare the protein expression of these mucins in mismatch repair-deficient and -proficient <z:hpo ids='HP_0003002'>breast cancers</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Cases of <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (n=100) were identified from families where (1) both breast and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> co-occurred and (2) families met either modified Amsterdam criteria or had at least one early-<z:hpo ids='HP_0003674'>onset</z:hpo> (&lt;50 years) <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumour</z:e> sections were stained for the epithelial mucins, MUC2, MUC5AC, MUC5B and MUC6, and the homeobox protein CDX2, a regulator of MUC2 expression </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo>, 16 mismatch repair-deficient <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> <z:hpo ids='HP_0003002'>breast cancers</z:hpo> and 84 non-Lynch <z:hpo ids='HP_0003002'>breast cancers</z:hpo> were assessed for altered mucin expression </plain></SENT>
<SENT sid="6" pm="."><plain>No significant difference in the expression of MUC2, MUC5AC or MUC6 was observed between the mismatch repair-deficient and mismatch repair-proficient <z:hpo ids='HP_0003002'>breast cancers</z:hpo>; however, there was a trend for mismatch repair-deficient <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> to express high levels of MUC5B less frequently (P=0.07, OR=0.2 (0.0-1.0)) </plain></SENT>
<SENT sid="7" pm="."><plain>Co-expression of two or more gel-forming mucins was common </plain></SENT>
<SENT sid="8" pm="."><plain>Ectopic expression of CDX2 was associated with expression of MUC2 (P=0.035, OR=8.7 (1.3-58.4)) </plain></SENT>
<SENT sid="9" pm="."><plain>Mismatch repair-deficient <z:hpo ids='HP_0003002'>breast cancers</z:hpo> do not show differential expression of the mucins genes on chromosome 11 when compared with mismatch repair-proficient <z:hpo ids='HP_0003002'>breast cancers</z:hpo>, in contrast with mismatch repair-deficient colorectal and <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancers</z:e>, which frequently have increased mucin protein expression when compared with their mismatch repair-proficient counterparts </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, ectopic CDX2 expression is positively associated with de novo MUC2 expression.Modern Pathology advance online publication, 1 February 2013; doi:10.1038/modpathol.2012.232 </plain></SENT>
</text></document>